Skip to main content
. 2011 Nov 2;6(11):e26508. doi: 10.1371/journal.pone.0026508

Figure 6. RNAi of KinesinCaaX show enhanced sensitivity to protein farnesyl transferase inhibitors but not other drugs.

Figure 6

(A) LN-59 (B) DFMO and (C) Pentamidine mean % growth (normalized to no drug) in induced and noninduced KinesinCaaX RNAi cells. (D) LN-59 (E) DFMO and (F) Pentamidine mean % growth in induced and noninduced GSK RNAi line. Values normalized to no drug with error bars representing SD.